Qianyuan Pharmaceutical: Announcement on the progress of investing in the establishment of a wholly-owned subsidiary and the transfer of part of Jiayi Pharmaceutical\'s shares
Qianyuan Pharmaceutical: Announcement of Resolutions of the 6th Extraordinary General Meeting of Shareholders in 2024
Qianyuan Pharmaceutical: Legal Opinion of Guohao Lawyer (Shanghai) Firm on the 6th Extraordinary General Meeting of Shareholders of Qianyuan Pharmaceutical in 2024
Qianyuan Pharmaceutical: Announcement on Repurchase and Cancellation of Restricted Shares, Reduction of Registered Capital and Notification to Creditors
Qianyuan Pharmaceutical: Prompt Announcement on Convening the 6th Extraordinary General Meeting of Shareholders in 2024
Qianyuan Pharmaceutical: Announcement on Subsidiaries Receiving Corporate Support Funds
Qianyuan Pharmaceutical: Announcement on relinquishing priority purchasing rights for holding subsidiaries and planning to sign shareholder agreements with new shareholders
Qianyuan Pharmaceutical: Notice on Convening the 6th Extraordinary General Meeting of Shareholders in 2024
Qianyuan Pharmaceutical: Announcement on the proposed establishment of a wholly-owned subsidiary to apply for merger and acquisition loans from banks and the company to provide guarantees
Qianyuan Pharmaceutical: Announcement on plans to invest in the establishment of a wholly-owned subsidiary and transfer part of Jiayi Pharmaceutical\'s shares
Qianyuan Pharmaceutical: Notice on changing the registered capital, amending the “Articles of Association”, and applying for registration of industrial and commercial changes
Qianyuan Pharmaceutical: Notice on completing the registration of industrial and commercial changes and issuing a business license
Qianyuan Pharmaceutical: Prompt Announcement on the Disclosure of the 2024 Semi-Annual Report
Qianyuan Pharmaceutical: Summary table of non-operating capital expenditure and other related capital transactions for the first half year of 2024
Shanxi C&Y Pharmaceutical Group: Announcement of the resolution of the fifth extraordinary shareholders' meeting in 2024.
Shanxi C&Y Pharmaceutical Group: Legal opinion from Guohao Law Firm (Shanghai) regarding the 5th interim shareholders' meeting of Shanxi C&Y Pharmaceutical Group in 2024.
Shanxi C&Y Pharmaceutical Group: Notice of the convening of the 5th interim shareholders' meeting in 2024.
Shanxi C&Y Pharmaceutical Group: Notice of the Fifth Temporary Shareholders' Meeting to be held in 2024.
Shanxi C&Y Pharmaceutical Group: Announcement regarding subsidiary obtaining invention patent.
Shanxi C&Y Pharmaceutical Group: Announcement of Resolutions of the Fourth Extraordinary Shareholders' Meeting in 2024.
No Data
No Data